SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-148119
Filing Date
2019-05-15
Accepted
2019-05-15 17:02:13
Documents
95
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d726255d10q.htm 10-Q 753457
2 EX-4.5 d726255dex45.htm EX-4.5 75168
3 EX-4.6 d726255dex46.htm EX-4.6 73558
4 EX-10.14 d726255dex1014.htm EX-10.14 27095
5 EX-10.15 d726255dex1015.htm EX-10.15 33420
6 EX-10.16 d726255dex1016.htm EX-10.16 33197
7 EX-10.17 d726255dex1017.htm EX-10.17 35879
8 EX-31.1 d726255dex311.htm EX-31.1 6400
9 EX-31.2 d726255dex312.htm EX-31.2 6413
10 EX-32.1 d726255dex321.htm EX-32.1 5507
  Complete submission text file 0001193125-19-148119.txt   6376137

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT xfor-20190331.xml EX-101.INS 1146337
12 XBRL TAXONOMY EXTENSION SCHEMA xfor-20190331.xsd EX-101.SCH 82689
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xfor-20190331_cal.xml EX-101.CAL 71831
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xfor-20190331_def.xml EX-101.DEF 291069
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE xfor-20190331_lab.xml EX-101.LAB 609870
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xfor-20190331_pre.xml EX-101.PRE 446544
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 19829423
SIC: 2836 Biological Products, (No Diagnostic Substances)